ALBAcheck-BGS Sensitivity Controls
30 November, 2009 byAlba Bioscience has added Anti-S (weak) to its range of control reagents namely, Anti-c (weak), Anti-Fya (weak), Anti-K (weak) and Anti-E (weak).
Lonza Potelligent CHOK1SV host cell line
20 November, 2009 byPotelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
Simplifying antibody conjugation processes
10 September, 2009Innova Biosciences has developed a conjugation technology called Lightning-Link that eliminates almost all of the steps employed in a traditional conjugation process.
Method to stabilise antibodies
07 September, 2009A technique for stabilising enzymes could lead to better biosensors, disease therapeutics and diagnostic reagents and non-laboratory applications, including environmental remediation.
High specificity clonal antibodies
08 July, 2009DB Biotech has introduced a new technology for the production of highly specific RABBIT CLONAL antibodies. In vitro cloning technology developed by the company enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes.
Range of antibodies
10 June, 2009Now available for the first time in Australia, the complete range of antibodies from Proteintech Group, Inc (PTG).
USP-NF compliant recombinant human albumins
09 June, 2009 byNovozymes Biopharma has announced that its Recombumin and albucult products comply with the new excipient monograph standard for recombinant human albumin, published in the United States Pharmacopoeia — National Formulary (USP-NF). The monograph was first published in November 2008 and became official on 1 May 2009. As these products comply with the monograph, their use eases the regulatory process for users and sets the industry benchmark for recombinant human albumin.
Biorisk-free growth factors and cytokines
09 June, 2009 byORF Genetics offers high-grade, biorisk-free growth factors and hard-to-express recombinant proteins from ISOkine.
Antibody range extended
05 June, 2009 byLeica Microsystems has added seven more antibodies to the Bond RTU range which now includes more than 100 clinically relevant antibodies prepared for use on the fully automated Bond IHC and ISH system.
Infectious disease antibodies
05 June, 2009 byThe Abcam portfolio of antibodies for bacteriology, protozoa and infectious diseases includes antibodies against: Anthrax, Aspergillus, Cholera Toxin, Campylobacter, Chlamydia, Clostridium botulinum, Helicobacter pylori, Mycobacterium tuberculosis, Salmonella, Staphylococcus and Streptococcus.
GPCR antibodies
07 April, 2009 byG protein-coupled receptors (GPCRs) are one of the major classes of drug targets and an estimated 30-50% of all marketed drugs act on them. They are integral membrane receptors that transmit signals from various small molecules, peptides and lipids via G proteins where they affect many physiological functions in almost all organs.
Antibody range
06 April, 2009 byThe Bond RTU Antibodies range has been expanded with the Phase 8 release, which includes the antibodies Bcl-2 and Mismatch Repair Protein.
Polyubiquitin antibody
01 January, 2009Biomol International has introduced a monoclonal antibody that specifically recognises K63-linked polyubiquitin, but not any other isopeptide-linked (K6, K11, K27, K29, K33 or K48) polyubiquitinylated species.
Antibodies
01 July, 2008Prestige Antibodies, powered by Atlas Antibodies, are developed and validated by the Human Proteome Resource (HPR) project.
Antibody learning website
01 June, 2008Millipore has launched its Antibody Learning Center — a free web tool for navigating Millipore’s broad antibody portfolio and planning efficient workflows for immunodetection in protein research.
